Somatostatin receptor imaging in patients with neuroendocrine tumors: not only SPECT?
- PMID: 17401084
- DOI: 10.2967/jnumed.106.038653
Somatostatin receptor imaging in patients with neuroendocrine tumors: not only SPECT?
Comment on
-
68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT.J Nucl Med. 2007 Apr;48(4):508-18. doi: 10.2967/jnumed.106.035667. J Nucl Med. 2007. PMID: 17401086 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources